UTAH MEDICAL PRODUCTS, INC. Acquisitions, Net of Cash Acquired
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2014-03-12
- UTAH MEDICAL PRODUCTS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2011-12-31 was $0.00.
- UTAH MEDICAL PRODUCTS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2011-09-30 was $0.00.
- UTAH MEDICAL PRODUCTS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2011-06-30 was $0.00.
- UTAH MEDICAL PRODUCTS, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2011-03-31 was $41.08M.
- UTAH MEDICAL PRODUCTS, INC. payments to acquire businesses, net of cash acquired for fiscal 2013 was $0.00.
- UTAH MEDICAL PRODUCTS, INC. payments to acquire businesses, net of cash acquired for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- UTAH MEDICAL PRODUCTS, INC. payments to acquire businesses, net of cash acquired for fiscal 2011 was $41.08M.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-12 | |||||
| 2012-12-31 | $0.00 10-K · filed 2014-03-12 | |||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $0.00 derived: sum of 2 quarters · filed 2014-03-12 | $0.00 derived: sum of 3 quarters · filed 2014-03-12 | $41.08M 10-K · filed 2014-03-12 | ||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $0.00 derived: sum of 2 quarters · filed 2012-11-09 | $41.08M 10-Q · filed 2012-11-09 | -$41.08M 10-Q · filed 2011-11-07 | ||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $41.08M 10-Q · filed 2012-08-08 | -$41.08M 10-Q · filed 2011-08-08 | |||
| 2011-03-31 | $41.08M 10-Q · filed 2012-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |